Active Early Detection Grants

PI Namesort ascending Organization - Company Title Major Program / Research Group FOA
Hruska, Carrie B Mayo Clinic Rochester Density MATTERS Clinical Trial PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Hayes, Richard Bernard New York University School Of Medicine The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer PA-19-056: Research Project Grant
Hall, Adam Roger Wake Forest University Health Sciences Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores RFA-CA-19-020: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Grogan, Eric L Vanderbilt University Medical Center Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Ghobrial, Irene M. Dana-Farber Cancer Inst Molecular prediction of myeloma in African Americans Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial PAR-18-913: Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
Georgakoudi, Irene Tufts University Medford Label-free, high resolution, functional, two-photon imaging for non-invasive early cancer detection PAR-18-021: NCI Small Grants Program for Cancer Research
Feng, Ziding Fred Hutchinson Cancer Center Consortium on Translational Research in Early Detection of Liver Cancer: Data Management and Coordinating Center (DMCC) Translational Liver Consortium RFA-CA-17-028: Coordinating Center for the Consortium of Translational Research in Early Detection of Liver Cancer
Esserman, Laura J University Of California, San Francisco Extending the Diversity, Reach, and Generalizability of the WISDOM Study PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Davis, Jennifer Sarah University Of Kansas Medical Center Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial PA-21-268: Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
Carlsson, Sigrid Sloan-Kettering Inst Can Research Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial PAR-18-913: Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
Bissonnette, Bruce Marc University Of Chicago Development of 5hmC and 5mC biomarkers in cell-free circulating DNA for sensitive colon cancer detection and prognosis Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial PAR-15-297: Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
Beane, Jennifer Ellen Boston University Medical Campus PRISTINE: Pre-cancer histology identification of Endobronchial biopsies using deep learning RFA-CA-19-038: ITCR: innovative algorithms
Ahn, Jiyoung New York University School Of Medicine The Oral Mycobiome and Risk of Pancreatic Cancer Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial PAR-18-913: Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
Agsalda-Garcia, Melissa Anne University Of Hawaii At Manoa Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients PAR-18-020: NCI Clinical and Translational Exploratory/Developmental Studies

Pages